Propionic Acid

Propionic Acid

SCHEMBL508030

CCC(=O)[O-].CCn1cc[n+](C)c1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FDPS P14324 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
MEN1 O00255 2/20 0.43
HSP90AA1 P07900 2/20 0.43
KMT2A Q03164 2/20 0.43
APAF1 O14727 1/20 0.43
NPC1 O15118 1/20 0.43
PLA2G1B P04054 1/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
RAB9A P51151 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
LMNA P02545 2/20 0.42
THRB P10828 1/20 0.31
HPGD P15428 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
PON1 P27169 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycolic Acid SCHEMBL2536925 0.93 FDPS (0.44) FDPSSMN1; SMN2MEN1HSP90AA1KMT2A
Bicarbonate SCHEMBL2936298 0.92 FDPS (0.46) FDPSSMN1; SMN2MEN1HSP90AA1KMT2A
Malonic Acid SCHEMBL2522780 0.91 FDPS (0.43) FDPSSMN1; SMN2MEN1HSP90AA1KMT2A
Bicarbonate SCHEMBL357949 0.91 FDPS (0.45) FDPSSMN1; SMN2MEN1HSP90AA1KMT2A
Bicarbonate SCHEMBL15404411 0.91 FDPS (0.45) FDPSSMN1; SMN2MEN1HSP90AA1KMT2A
Acetic Acid SCHEMBL302143 0.91 FDPS (0.45) FDPSSMN1; SMN2MEN1HSP90AA1KMT2A
Glycine SCHEMBL15400135 0.89 FDPS (0.42) FDPSSMN1; SMN2MEN1HSP90AA1KMT2A
Oxalic Acid SCHEMBL17710444 0.89 SMN1; SMN2 (0.47) FDPSSMN1; SMN2MEN1HSP90AA1KMT2A
Butyric Acid SCHEMBL509160 0.88 FFAR3 (0.47) FDPSSMN1; SMN2MEN1HSP90AA1KMT2A
Acetic Acid SCHEMBL28506136 0.87 FDPS (0.43) FDPSSMN1; SMN2MEN1HSP90AA1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3257569-A1 METHOD FOR THE REMOVAL OF MOISTURE FROM MOIST GAS MIXTURES Evonik Degussa GmbH (DE) 2017-12-20 EP claimed
US-9758377-B2 Extraction of hydroxyapatite from fish scales employing ionic liquids COMSATS INSTITUTE OF INFORMATION TECHNOLOGY 2017-09-12 US claimed
US-20160376149-A1 EXTRACTION OF HYDROXYAPATITE FROM FISH SCALES EMPLOYING IONIC LIQUIDS COMSATS INSTITUTE OF INFORMATION TECHNOLOGY (PK) 2016-12-29 US claimed
US-8841441-B2 Method for producing regenerated biopolymers and regenerated products obtained by said method BASF SE (DE) 2014-09-23 US claimed
US-8546109-B2 Biomass pretreatment SUGANIT SYSTEMS, INC. (US) 2013-10-01 US claimed
EP-1966284-B1 SOLVENT SYSTEM BASED ON MOLTEN IONIC LIQUIDS, ITS PRODUCTION AND USE FOR PRODUCING REGENERATED CARBOHYDRATES BASF SE (DE) 2013-04-17 EP claimed
US-20120193046-A1 BIOMASS PRETREATMENT SUGANIT SYSTEMS, INC. (US) 2012-08-02 US claimed
US-8163215-B2 Contains 1-ethyl-3-methylimidazolium acetate; precipitation; spun fibers BASF AKTIENGESELLSCHAFT (DE) 2012-04-24 US claimed
US-20120095207-A1 CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2012-04-19 US claimed
US-8153782-B2 Cellulose esterification; ion exchanging; acylation; slurrying EASTMAN CHEMICAL COMPANY (US) 2012-04-10 US claimed
EP-2062922-A1 Method for manufacturing regenerated biopolymers and regenerated products created therewith BASF SE (DE) 2009-05-27 EP claimed
US-20080269477-A1 Solvent System Based on Molten Ionic Liquids, Its Production and Use for Producing Regenerated Carbohydrates BASF SE (DE) 2008-10-30 US claimed
WO-2008112291-A2 BIOMASS PRETREATMENT THE UNIVERSITY OF TOLEDO (US) 2008-09-18 WO claimed
US-20080227162-A1 Lignocellulose conversion to sugar with improvements in yield and rate of sugar production by using ionic liquid pretreatment; conversion of the swollen biomass to useful chemicals, biofuels SUGANIT SYSTEMS, INC. 2008-09-18 US claimed
WO-2008100569-A1 REFORMATION OF IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-21 WO claimed
WO-2008100577-A1 PRODUCTION OF IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-21 WO claimed
WO-2008100566-A1 CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-21 WO claimed
US-20080194834-A1 PRODUCTION OF IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-14 US claimed
US-20080194808-A1 CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-14 US claimed
US-20080194807-A1 REFORMATION OF IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194834-A1 PRODUCTION OF IONIC LIQUIDS GLUL, ICMT, ALAD FDPS 1422/4885SMN1; SMN2 2913/4885MEN1 3148/4885
US-20080194808-A1 CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS CEL, ACMSD, ACOT7 FDPS 1470/4885SMN1; SMN2 3897/4885MEN1 3042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.